View drug registration information details.
| Items | Registration information |
|---|
| ID | 322 |
|---|
| No | 322 |
|---|
| Brand Name | HOVID-XYFISIM CAPSULE 200 MG |
|---|
| Ingredients | CEFIXIME 200 MG |
|---|
| Dosage Form | CAPSULE |
|---|
| Primary Packaging | PVC/ALU BLISTERPACK |
|---|
| Storage | STORE BELOW 30C |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 1 X 6'S AND 10 X 6'S |
|---|
| Dispensing Category | PRESCRIPTION |
|---|
| ATC Classification | J01DD08 |
|---|
| Pharmaceutical Class | ANTIBACTERIA |
|---|
| Indications | UPPER AND LOWER RESPIRATORY TRACT INFECTION, URINARY TRACT INFECTION |
|---|
| Contraindications | HYPERSENSITIVITY |
|---|
| Side Effects | HEADACHE, DIZZINESS, DYSPNOEA, ABDOMINAL PAIN, DIARRHEA, DYSPEPSIA, NAUSEA, VOMITING, FLATULANCE |
|---|
| Unit Price | |
|---|
| EDL |
Yes |
|---|
| Description | YELLOW OPAQUE HARD GELATIN CAPSULE CONTAINING WHITE TO PALE YELLOW POWDER |
|---|
| Note | |
|---|
| License Owner | BMS PHARMA SOLE CO.,LTD |
|---|
| Manufacturer | SINOPHARM ZHIJUN(SHENZHEN) PHARMACEUTICAL CO.,LTD |
|---|
| Country | CHINA |
|---|
| Import Registration No | H20040725 |
|---|
| Import Registration Date | 22-11-2019 |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | 2023-05-08 |
|---|
| FDD Registration No | 04 I 5728/24 |
|---|
| FDD Registration Date | 26/4/2024 |
|---|
| Expiry Date | 25/4/2027 |
|---|
Back to drug list
|
